These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 14626567

  • 21. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R, Sobra J, Kvasnicka J, Procházková R, Kvasilová M, Haas T.
    Cas Lek Cesk; 1996 Jul 26; 135(13):413-6. PubMed ID: 8925538
    [Abstract] [Full Text] [Related]

  • 22. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW.
    Curr Med Res Opin; 2008 Mar 26; 24(3):685-94. PubMed ID: 18226326
    [Abstract] [Full Text] [Related]

  • 23. Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study.
    Reckless JP, Henry P, Pomykaj T, Lim ST, Massaad R, Vandormael K, Johnson-Levonas AO, Lis K, Brudi P, Allen C.
    Int J Clin Pract; 2008 Apr 26; 62(4):539-54. PubMed ID: 18266852
    [Abstract] [Full Text] [Related]

  • 24. Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia.
    McKenney JM, Farnier M, Lo KW, Bays HE, Perevozkaya I, Carlson G, Davies MJ, Mitchel YB, Gumbiner B.
    J Am Coll Cardiol; 2006 Apr 18; 47(8):1584-7. PubMed ID: 16630994
    [Abstract] [Full Text] [Related]

  • 25. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
    Stender S, Schuster H, Barter P, Watkins C, Kallend D, MERCURY I Study Group.
    Diabetes Obes Metab; 2005 Jul 18; 7(4):430-8. PubMed ID: 15955130
    [Abstract] [Full Text] [Related]

  • 26. [Antilipemic therapy and rhabdomyolysis].
    Paragh G, Balogh Z, Romics L.
    Orv Hetil; 2003 Mar 16; 144(11):515-20. PubMed ID: 12731338
    [Abstract] [Full Text] [Related]

  • 27. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.
    Am J Geriatr Pharmacother; 2005 Dec 16; 3(4):218-28. PubMed ID: 16503317
    [Abstract] [Full Text] [Related]

  • 28. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.
    Int J Cardiol; 2005 Oct 10; 104(3):338-45. PubMed ID: 16186066
    [Abstract] [Full Text] [Related]

  • 29. Combined treatment with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemia.
    Liamis G, Kakafika A, Bairaktari E, Miltiadous G, Tsimihodimos V, Goudevenos J, Achimastos A, Elisaf M.
    Curr Med Res Opin; 2002 Oct 10; 18(3):125-8. PubMed ID: 12094821
    [Abstract] [Full Text] [Related]

  • 30. Comparison of the efficacy and safety of pravastatin and simvastatin in heart transplantation.
    Vivekananthan K, Mehra MR, Uber PA, DeGruiter H, Lavie CJ, Milani RV.
    J Assoc Physicians India; 2002 May 10; 50(5):682-4. PubMed ID: 12186124
    [Abstract] [Full Text] [Related]

  • 31. Fenofibric acid: in combination therapy in the treatment of mixed dyslipidemia.
    Yang LP, Keating GM.
    Am J Cardiovasc Drugs; 2009 May 10; 9(6):401-9. PubMed ID: 19929038
    [Abstract] [Full Text] [Related]

  • 32. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin.
    Jones PH, Davidson MH.
    Am J Cardiol; 2005 Jan 01; 95(1):120-2. PubMed ID: 15619408
    [Abstract] [Full Text] [Related]

  • 33. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec 01; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
    Brudi P, Reckless JP, Henry DP, Pomykaj T, Lim ST, Massaad R, Vandormael K, Johnson-Levonas AO.
    Cardiology; 2009 Dec 01; 113(2):89-97. PubMed ID: 19018143
    [Abstract] [Full Text] [Related]

  • 35. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 01; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 36. Statin-fibrate combinations in patients with combined hyperlipedemia.
    Athyros VG, Papageorgiou AA, Kontopoulos AG.
    Atherosclerosis; 2001 Mar 01; 155(1):263-4. PubMed ID: 11293392
    [No Abstract] [Full Text] [Related]

  • 37. Combination fibrate-statin therapy for the treatment of severe hypertriglyceridaemia in renal disease.
    Badawy O, Wierzbicki AS, Hilton R.
    Int J Clin Pract; 2003 Apr 01; 57(3):249-51. PubMed ID: 12723736
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
    Davidson MH, Stein EA, Bays HE, Maki KC, Doyle RT, Shalwitz RA, Ballantyne CM, Ginsberg HN, COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators.
    Clin Ther; 2007 Jul 01; 29(7):1354-67. PubMed ID: 17825687
    [Abstract] [Full Text] [Related]

  • 39. Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapy.
    Farnier M, Ducobu J, Bryniarski L.
    Curr Med Res Opin; 2011 Nov 01; 27(11):2165-73. PubMed ID: 21973199
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of three statins at lower maintenance doses.
    Carr-Lopez S, Exstrum T, Morse T, Shepherd M, Bush AC.
    Clin Ther; 1999 Feb 01; 21(2):331-9. PubMed ID: 10211536
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.